MedPath

UNICORNS: Uveitis in Childhood Prospective National Cohort Study

Active, not recruiting
Conditions
Uveitis
Registration Number
NCT05385757
Lead Sponsor
Institute of Child Health
Brief Summary

Childhood uveitis (inflammation inside the eye) is an uncommon disorder that carries the risk of blindness. Inadequate treatment of active inflammation has been shown to be related to a poor outcome. There has been no population-based, prospective longitudinal study of all-cause childhood uveitis, with resultant limitations in the evidence base used to counsel affected families, balance treatment decisions, or plan further research. The aim of the study is to describe the characteristics of childhood-onset uveitis and describe outcomes. The investigators shall also aim to identify the socio-demographic, clinical, biological and treatment-related determinants of outcome. Early (1-2 years following diagnosis) outcomes will be described in the first instance: However, through the creation of a national inception cohort, the investigators shall enable longer-term studies of outcome for affected children and families. There will be no change to routine clinical care.

Detailed Description

Background:

Childhood uveitis descriptive term for a group of rare inflammatory eye disease, which are typically chronic, relapsing-remitting in nature, and of uncertain aetiology (idiopathic). Visual loss occurs due to structural damage caused by uncontrolled inflammation. Understanding of the determinants of long-term outcome is limited, particularly the predictors of therapeutic response or how to define disease control.

Aims:

To describe disease natural history and outcomes amongst a nationally representative group of children with non-infectious uveitis, describe the impact of disease course on quality of life for both child and family, and identify determinants of adverse visual, structural and developmental outcomes.

Methods:

UNICORNS is a prospective longitudinal multicentre cohort study of children newly diagnosed with uveitis about whom a core minimum clinical dataset will be collected. Participants and their families will also complete patient-reported outcome measures (PROMS) at study entry and annually from recruitment.

PROMS collected at baseline are:

* Strength and Difficulties Questionnaire (SDQ): this is to screen the emotional and behavioural aspects of the participants' lives

* Child Health Utility 9D (CHU9D): generic preference based measure of health related quality of life

* Children's Sleep Habits Questionnaire (CHSQ): this evaluates incidence of behaviours linked with typical paediatric sleep difficulties

* 100-mm General Evaluation (GE): visual analogue score 100mm long used to capture overall perception of the burden of disease

PROMS collected at year 1 and annually (subject to investigations of instrument redundancy) are:

* Child Health Utility 9D (CHU9D): generic preference based measure of health related quality of life

* 100-mm General Evaluation (GE): visual analogue score 100mm long used to capture overall perception of the burden of disease

* Paediatric Quality of life Score (PedsQL): a brief questionnaire used to evaluate health related quality of life in children

* Vision related quality of life metric - Children and Young People (VQoL_CYP): these instruments captures the functional and broader impacts of living with a visual disability The association of patient (child- and treatment- dependent) characteristics with outcome will be investigated using logistic and ordinal regression models which incorporate adjustment for within-child correspondence between eyes for those with bilateral disease and repeated outcomes measurement.

Discussion:

Through this population based, prospective longitudinal study of childhood uveitis, the investigators will describe the characteristics of childhood onset disease. Early (1-2 years following diagnosis) outcomes will be described in the first instance, and through the creation of a national inception cohort, longer term studies of outcome for affected children and families will be enabled.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Children newly diagnosed with uveitis (within previous 6 months)
  • Age < 18years
Read More
Exclusion Criteria
  • Uveitis due to malignancy
  • Uveitis due to ocular trauma (including iatrogenic, ie intraocular surgery)
  • Uveitis due to confirmed ocular infection
  • Children with developmental disorders or impairments which prevent their self-report of their function level or quality of life
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of ocular complicationsUp to 3 years

New incident of sight threatening ocular complications, including glaucoma, cataract and macular oedema

Pediatric Quality of Life Inventory ScoreUp to 3 years

Quality of life (patient reported outcomes) using Pediatric Quality of Life Inventory (PedsQL) in which items are reversed scored and linearly transformed to a 0-100 scale, so that higher scores indicate better HRQOL (Health-Related Quality of Life)

Secondary Outcome Measures
NameTimeMethod
Change in Pediatric Quality of Life Inventory ScoreOver one year from baseline to year one

Change in child reported quality of life using Pediatric Quality of Life Inventory (PedsQL) in which items are reversed scored and linearly transformed to a 0-100 scale, so that higher scores indicate better HRQOL (Health-Related Quality of Life), and a change of greater than 5 is clinically meaningful

Health UtilityUp to 3 years

Child Health Utility Metric (CHU9D), with scores ranging from 0.33 (worst health state) to 1.00 (best health state)

Corticosteroid exposureUp to 3 years

Total prescribed topical and systemic corticosteroid burden

Attainment of disease controlUp to 3 years

Number of children achieving absolute control defined as absence of inflammation Relative control defined as the absence of inflammation greater than 0.5 The lowest grade of inflammation, with the use of less than one drop of topical corticosteroid

Trial Locations

Locations (31)

Bradford Teaching Hospitals NHS Foundation Trust

🇬🇧

Bradford, United Kingdom

Belfast Royal Victoria Hospital NHS Foundation Trust

🇬🇧

Belfast, United Kingdom

University Hospitals Bristol NHS Foundation Trust

🇬🇧

Bristol, United Kingdom

Birmingham Women's and Children's Hospital NHS Foundation Trust

🇬🇧

Birmingham, United Kingdom

Nottingham University Hospitals NHS Trust

🇬🇧

Nottingham, United Kingdom

Moorfields Eye Hospital NHS Foundation Trust

🇬🇧

London, United Kingdom

Cardiff and Vale University Health Board Hospitals

🇬🇧

Cardiff, United Kingdom

Cambridge University Hospital NHS Foundation Trust

🇬🇧

Cambridge, United Kingdom

Mid Essex Hospital Trust

🇬🇧

Chelmsford, United Kingdom

Royal Children's Hospital

🇬🇧

Glasgow, United Kingdom

Sussex Eye Hospital and Royal Alexandra Children's Hospital

🇬🇧

Redhill, United Kingdom

Princess Alexandra Eye Pavilion

🇬🇧

Edinburgh, United Kingdom

James Paget University Hospitals NHS Foundation Trust

🇬🇧

Great Yarmouth, United Kingdom

Maidstone and Tunbridge Wells NHS Trust

🇬🇧

Maidstone, United Kingdom

Leeds Teaching Hospitals NHS Trust

🇬🇧

Leeds, United Kingdom

Ninewells Hospital

🇬🇧

Dundee, United Kingdom

Alder Hey Hospital NHS Foundation Trust

🇬🇧

Liverpool, United Kingdom

Newcastle Upon Tyne Hospitals NHS Foundation Trust

🇬🇧

Newcastle, United Kingdom

Sheffield Children's Hospitals NHS Foundation Trust

🇬🇧

Sheffield, United Kingdom

Royal London Hospital

🇬🇧

Whitechapel, United Kingdom

Royal Bournemouth Christchurch Hospitals NHS Foundation Trust

🇬🇧

Bournemouth, United Kingdom

Great Ormond Street Hospital NHS Foundation Trust

🇬🇧

London, United Kingdom

Southend University Hospital NHS Foundation Trust

🇬🇧

Westcliff-on-Sea, United Kingdom

York Teaching Hospital NHS Foundation Trust

🇬🇧

York, United Kingdom

Norfolk and Norwich University Hospitals NHS Foundation Trust

🇬🇧

Norwich, United Kingdom

Oxford University Hospitals NHS Foundation Trust

🇬🇧

Oxford, United Kingdom

University Hospital Southampton NHS Foundation Trust

🇬🇧

Southampton, United Kingdom

Manchester University NHS Foundation Trust

🇬🇧

Manchester, United Kingdom

St Thomas' Hospital

🇬🇧

London, United Kingdom

Royal Free London NHS Foundation Trust

🇬🇧

London, United Kingdom

Hull University Teaching Hospitals NHS Trust

🇬🇧

Hull, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath